Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia - Poon - 2021 - International Journal of Gynecology & Obstetrics - Wiley Online Library

PDF] Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial

Healthcare, Free Full-Text

IJERPH, Free Full-Text

Full article: Selecting emergency therapy for patients with pre-eclampsia

The Lancet, 21 September 2019, Volume 394, Issue 10203, Pages 979-1112

Impact of Chronic Hypertension and Antihypertensive Treatment on Adverse Perinatal Outcomes: Systematic Review and Meta‐Analysis

Solubility of Nifedipine by Shake Flask UV-Spectrometry; Review of Safety Concerns in Pregnancy – Biomedical and Pharmacology Journal

Hypertension during pregnancy: Studies reveal an oral, inexpensive treatment for controlling BP-Health News , Firstpost

Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. - Abstract - Europe PMC

Comparative maternal outcomes of oral nifedipine and intravenous labetalol for severe hypertension during pregnancy: an open label randomized controlled trial. - Document - Gale Academic OneFile

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy - Abalos, E - 2018

PDF) Comparison of effect of nifedipine, labetalol and methyldopa in treatment of hypertension in pregnancy in a tertiary care government hospital